✦ LIBER ✦

Cost–Utility of Adjuvant High-Dose Interferon Alpha Therapy in Stage III Cutaneous Melanoma in Quebec

✍ Scribed by R. Crott; F. Ali; S. Burdette-Radoux

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A retrospective cost-effectiveness analy

✍ A. Messori; P. Becagli; S. Trippoli; E. Tendi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 1003 KB

Economic analysis of adjuvant therapy wi

✍ A. Lafuma; B. Dreno; M. Delaunay; C. Emery; F. Fagnani; K. Hieke; J.-J. Bonerand 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Toxicity and feasibility of adjuvant hig

✍ C. Bédane; A. Ravaud; L. Geoffrois; t. Lesimple; M. Delaunay; J.M. Bonnetblanc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

PCN27 COST-EFFECTIVENESS OF HUMAN INTERF

✍ F Kasteng; R Stadler; G Wagenius; J Lundkvist 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Cost-effectiveness analysis of interfero

✍ J.L González-Larriba; S Serrano; M Alvarez-Mon; F Camacho; M.A Casado; J.L Dı́az 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Toxicity and feasibility of adjuvant hig

✍ Ravaud, A; Bedane, C; Geoffrois, L; Lesimple, T; Delaunay, M 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 49 KB